Acelrx Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Acelrx Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Acelrx Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Acelrx Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $25k | 28k | 0.91 |
| 2025-06-30 | $9 | 22 | 0.45 |
| 2025-03-31 | $11 | 22 | 0.50 |
| 2024-12-31 | $12 | 22 | 0.55 |
| 2024-09-30 | $38k | 44k | 0.86 |
| 2024-06-30 | $20 | 22 | 0.91 |
| 2024-03-31 | $2.8k | 2.7k | 1.05 |
| 2023-12-31 | $8.3k | 11k | 0.73 |
| 2023-09-30 | $41 | 72 | 0.58 |
| 2023-06-30 | $23 | 22 | 1.09 |
| 2023-03-31 | $4.7k | 7.0k | 0.67 |
| 2022-12-31 | $4.2k | 1.9k | 2.25 |